Clinical Trial

Bioequivalence Study of Dronedarone Hydrochloride Tablets

Name: Bioequivalence Study of Dronedarone Hydrochloride Tablets — clinical trial record (NCT07396519)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The test formulation of Dronedarone Hydrochloride Tablets (400 mg) is bioequivalent to the reference formulation (MULTAQ®) in healthy Chinese subjects under fed conditions.

Trial Details

NCT Number	NCT07396519
Lead Sponsor	Shandong New Time Pharmaceutical Co., LTD
Conditions	Atrial Fibrillation (AF)
Enrollment	48 participants
Start Date	2022-11-14
Primary Completion	2022-12-07 (estimated)
Study Completion	2022-12-07 (estimated)
Updated on ClinicalTrials.gov	2026-02-09